Skip to main content
Clinical Trials/JPRN-UMIN000054127
JPRN-UMIN000054127
Not yet recruiting
未知

A multicenter observational study to evaluate the efficacy and safety of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in patients with unresectable neuroendocrine tumors (NEN). - A multicenter observational study to evaluate the efficacy and safety of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in patients with unresectable neuroendocrine tumors (NEN).

ational cancer center0 sites200 target enrollmentApril 12, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ational cancer center
Enrollment
200
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 12, 2024
End Date
June 30, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ational cancer center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials